These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 18175395)

  • 61. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.
    Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V
    Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Parkinsonism genes: culprits and clues.
    Abeliovich A; Flint Beal M
    J Neurochem; 2006 Nov; 99(4):1062-72. PubMed ID: 16836655
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Function study advances of Parkinson disease related genes].
    Wang XM; Wang DQ; Wang XY
    Yi Chuan; 2010 Aug; 32(8):779-84. PubMed ID: 20709674
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
    Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
    Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
    Kilarski LL; Pearson JP; Newsway V; Majounie E; Knipe MD; Misbahuddin A; Chinnery PF; Burn DJ; Clarke CE; Marion MH; Lewthwaite AJ; Nicholl DJ; Wood NW; Morrison KE; Williams-Gray CH; Evans JR; Sawcer SJ; Barker RA; Wickremaratchi MM; Ben-Shlomo Y; Williams NM; Morris HR
    Mov Disord; 2012 Oct; 27(12):1522-9. PubMed ID: 22956510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Unravelling the role of defective genes.
    Cookson MR
    Prog Brain Res; 2010; 183():43-57. PubMed ID: 20696314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetics of parkinsonism.
    Bonifati V
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S233-41. PubMed ID: 18267242
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New Developments in Genetic rat models of Parkinson's Disease.
    Creed RB; Goldberg MS
    Mov Disord; 2018 May; 33(5):717-729. PubMed ID: 29418019
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.
    Ferreira JJ; Guedes LC; Rosa MM; Coelho M; van Doeselaar M; Schweiger D; Di Fonzo A; Oostra BA; Sampaio C; Bonifati V
    Mov Disord; 2007 Jun; 22(8):1194-201. PubMed ID: 17469194
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genes associated with Parkinson syndrome.
    Biskup S; Gerlach M; Kupsch A; Reichmann H; Riederer P; Vieregge P; Wüllner U; Gasser T
    J Neurol; 2008 Sep; 255 Suppl 5():8-17. PubMed ID: 18787878
    [TBL] [Abstract][Full Text] [Related]  

  • 74. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
    Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Genetics and present therapy options in Parkinson's disease: a review].
    Bereznai B; Molnar MJ
    Ideggyogy Sz; 2009 May; 62(5-6):155-63. PubMed ID: 19579663
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Etiology and pathogenesis of Parkinson disease.
    Schapira AH
    Neurol Clin; 2009 Aug; 27(3):583-603, v. PubMed ID: 19555823
    [TBL] [Abstract][Full Text] [Related]  

  • 77. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
    Abbas N; Lücking CB; Ricard S; Dürr A; Bonifati V; De Michele G; Bouley S; Vaughan JR; Gasser T; Marconi R; Broussolle E; Brefel-Courbon C; Harhangi BS; Oostra BA; Fabrizio E; Böhme GA; Pradier L; Wood NW; Filla A; Meco G; Denefle P; Agid Y; Brice A
    Hum Mol Genet; 1999 Apr; 8(4):567-74. PubMed ID: 10072423
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Behavioral testing regimens in genetic-based animal models of Parkinson's disease: cogencies and caveats.
    Bury A; Pienaar IS
    Neurosci Biobehav Rev; 2013 Jun; 37(5):846-59. PubMed ID: 23558176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.